Evaluation of Interleukin-6, Leukotriene B-4, and Nitric Oxide Levels in Exhaled Breath Condensate of Asymptomatic Obese Individuals: Are Obese Patients Under Risk of Developing Asthma?
The mean age of the obese group (38.7±11.4 years) wassignificantly higher than the one of the non-obese group (29.5±8.6 years; p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Objective: If systemic inflammation in relation with obesity causes asthma, the detection of increased airwayinflammation among obese individuals who do not have any respiratory symptoms can be also beneficial inindentifying obese patients who are at risk of developing asthma.
📊
Temel Bulgular & Veri:The aim of this study was to evaluate thesystemic and airway inflammation of asymptomatic obese and non-obese individuals.Materials and Methods: Obese and non-obese individuals with no respiratory symptoms were included.Inflammatory biomarkers such as C-reactive protein (CRP), exhaled breath condensate (EBC) interleukin-6(IL-6), EBC leukotriene B-4 (LTB-4), and EBC nitric oxide (NO) levels of obese and non-obese individualswere determined.Results: Forty-five obese individuals (body mass index [BMI]≥30) and 31 non-obese individuals (BMI≤25)as a control group were included in this study.
💡
Sonuç & Katkı:The mean age of the obese group (38.7±11.4 years) wassignificantly higher than the one of the non-obese group (29.5±8.6 years; p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Objective: If systemic inflammation in relation with obesity causes asthma, the detection of increased airwayinflammation among obese individuals who do not have any respiratory symptoms can be also beneficial inindentifying obese patients who are at risk of developing asthma. The aim of this study was to evaluate thesystemic and airway inflammation of asymptomatic obese and non-obese individuals.Materials and Methods: Obese and non-obese individuals with no respiratory symptoms were included.Inflammatory biomarkers such as C-reactive protein (CRP), exhaled breath condensate (EBC) interleukin-6(IL-6), EBC leukotriene B-4 (LTB-4), and EBC nitric oxide (NO) levels of obese and non-obese individualswere determined.Results: Forty-five obese individuals (body mass index [BMI]≥30) and 31 non-obese individuals (BMI≤25)as a control group were included in this study. The mean age of the obese group (38.7±11.4 years) wassignificantly higher than the one of the non-obese group (29.5±8.6 years; p
🔖
Bu Makaleye Atıf Yap
ÇELİKEL, S., ÇELİK, D., GEGİN, S., PAZARLI, A. C. (2022). Evaluation of Interleukin-6, Leukotriene B-4, and Nitric Oxide Levels in Exhaled Breath Condensate of Asymptomatic Obese Individuals: Are Obese Patients Under Risk of Developing Asthma?. Eurasian Journal of Medicine, Cilt: 52 - Sayı: 1, 25–28. https://ajindex.com/articles/509363
WHO global infobase: data on overweight and obesity, mean BMI, healty diets and physical inactivity, WHO Bulletin 2011
Chen Y, Rennie D, Cormier Y, Dosman J. Sex specificity of asthma associated with objectively measured body mass index and waist circumference. Chest 2005; 128: 3048-54. [CrossRef] 3. Ford ES, Mannino DM, Redd SC, Mokdad AH, Mott JA. Body mass index and asthma incidence among USA adults. Eur Respir J 2004; 24: 740-4. [CrossRef] 4. Hancox RJ, Milne BJ, Poulton R, et al. Sex differences in the relation between body mass index and asthma and atopy in a birth cohort. Am J Respir Crit Care Med 2005; 171: 440- 5. [CrossRef] 5. Luder E, Ehrlich RI, Lou WY, Melnik TA, Kattan M. Body mass index and the risk of asthma in adults. Respir Med 2004; 98: 29- 37. [CrossRef] 6. Weiss ST, Shore SA. Obesity and asthma: direction for research. Am J Respir Crit Care Med 2004; 169: 963-8. [CrossRef] 7. Beuther D, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med 2006; 174: 112-9. [CrossRef] 8. Lu Y, Van Bever HP, Lim TK, et al. Obesity, asthma prevalence and IL-4: Roles of inflammatory cytokines, adiponectin and neuropeptide Y. Pediatr Allergy Immunol 2015; 26: 530-6. [CrossRef] 9. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 2011; 131: 485-91. [CrossRef] 10. Miller MR, Hankinson J, Brusasco V, et al. ATS/ ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 26: 319-38. [CrossRef] 11. Fornadley JA. Skin testing for inhalant allergy. Int Forum Allergy Rhinol 2014; 4 Suppl 2: S41-5. [CrossRef] 12. Gümüşdiş G, Doğanavşargil G. Klinik Romatoloji, 1. Edition. İstanbul Deniz Matbaası 1999; 423-39
Festa A, D'Agostino R Jr, Williams K, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001; 25: 1407-15. [CrossRef] 14. Saijo Y, Kiyota N, Kawasaki Y, et al. Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 2004; 6: 249-58. [CrossRef] 15. Leung TF, Li CY. The relation between obesity and astmatic airway inflammation. Pediatr Allergy Immunol 2004; 15: 344-50. [CrossRef] 16. Oğuzülgen İK, Turktaş H, Levent E, Erbaş D. Akut astma atağındaki hastalarda ekshale nitrik oksit ölçümü. Tuberk Toraks 1999; 47: 259-64
Smith AD, Cowan JO, Brassett KP Herbison GP, Taylor DR. Use of exhaled